<DOC>
	<DOCNO>NCT00135304</DOCNO>
	<brief_summary>The purpose study compare proportion chronic kidney disease ( CKD ) subject dialysis receive Sensipar® low dose vitamin D escalating dos vitamin D alone able achieve National Kidney Foundation-Kidney Disease Outcomes Quality Initiative ( NKF-K/DOQI ) secondary hyperparathyroidism ( HPT ) treatment target biointact parathyroid hormone ( biPTH ) calcium-phosphorus ( Ca x P ) product .</brief_summary>
	<brief_title>ACHIEVE : Optimizing Treatment Secondary Hyperparathyroidism</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>On hemodialysis least 3 month receive intravenous vitamin D therapy ( paricalcitol doxercalciferol ) least 3 month prior enter screen Historical iPTH 150800 pg/ml ( biPTH 80430 pg/ml ) within 6 month correct serum Ca great 8.4 mg/dl within 2 month prior screen period . For subject biPTH 80160 pg/ml ( iPTH 150300 pg/ml ) , Ca x P must great 55 mg²/dl² within 2 month prior screen period Screening ( prewashout ) biPTH 80430 pg/ml correct serum Ca level great 8.4 mg/dl . For subject biPTH 80160 pg/ml Ca x P must also great 55 mg²/dl² Baseline mean biPTH ( postwashout ) great 160 pg/ml mean correct Ca great 8.4 mg/dl Parathyroidectomy 3 month period prior screen Current gastrointestinal disorder may associate impaired absorption orally administer medication inability swallow tablet Use investigational drug device participation trial investigational drug device within 30 day screen Females child bear potential pregnant ( e.g. , positive pregnancy test ) breast feeding refuse use highly effective contraceptive measure ( determine investigator ) throughout study Previously participate Sensipar® study receive receive Sensipar® commercially available product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Sensipar®</keyword>
	<keyword>Cinacalcet HCl</keyword>
	<keyword>Chronic Kidney Disease</keyword>
</DOC>